FDA Approved: NAYZILAM — Original Application (UCB, Inc.)

View source ↗

Summary

The FDA approved Nayzilam, a nasal spray form of midazolam, under an original NDA for the acute treatment of seizures in people with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• NAYZILAM (midazolam)

Snippet

ORIG AP for NAYZILAM (MIDAZOLAM)